Skip to main content
Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

1 Aufruf
Herunterladen
Pharmazeutisch

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.

Dosierung

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Stärke

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Packungsgröße

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Form

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Sicherheitsprofil

Kontraindikationen

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Nebenwirkungen

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Verwandte klinische Artikel

Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.

QR Code